Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms,… Read more
Labiana Health S.A. - Asset Resilience Ratio
Labiana Health S.A. (LAB) has an Asset Resilience Ratio of 4.19% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2022)
This chart shows how Labiana Health S.A.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Labiana Health S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €2.52 Million | 4.15% |
| Short-term Investments | €23.38K | 0.04% |
| Total Liquid Assets | €2.54 Million | 4.19% |
Asset Resilience Insights
- Limited Liquidity: Labiana Health S.A. maintains only 4.19% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Labiana Health S.A. Industry Peers by Asset Resilience Ratio
Compare Labiana Health S.A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Cronos Group Inc
NASDAQ:CRON |
Drug Manufacturers - Specialty & Generic | 3.34% |
|
Evoke Pharma Inc
NASDAQ:EVOK |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Medical Marijuana I
PINK:MJNA |
Drug Manufacturers - Specialty & Generic | 0.03% |
|
James E Wagner Cultivation Corp
PINK:JWCAF |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
CanaQuest Medical Corp
PINK:CANQF |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Biostar Pharmaceuticals Inc
PINK:BSPM |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Innovativ Media Group Inc
PINK:DMAN |
Drug Manufacturers - Specialty & Generic | 53.58% |
Annual Asset Resilience Ratio for Labiana Health S.A. (2022–2022)
The table below shows the annual Asset Resilience Ratio data for Labiana Health S.A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 4.19% | €2.54 Million | €60.78 Million | -- |